Concession growth, insulin expansion to drive Pharmaniaga's earnings outlook

KUALA LUMPUR: Pharmaniaga Bhd expects continued growth in its concession business after the government raised the allocation under the system to RM2.1 billion this year from RM2 billion in 2025.

Original source: New Straits Times